152 related articles for article (PubMed ID: 36386175)
1. The association of
Chappell K; Ait Tayeb AEK; Colle R; Bouligand J; El-Asmar K; Gressier F; Trabado S; David DJ; Feve B; Becquemont L; Corruble E; Verstuyft C
Front Pharmacol; 2022; 13():974570. PubMed ID: 36386175
[No Abstract] [Full Text] [Related]
2. The
Chappell K; Colle R; Bouligand J; Trabado S; Fève B; Becquemont L; Corruble E; Verstuyft C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613935
[TBL] [Abstract][Full Text] [Related]
3. The GG genotype of the serotonin 4 receptor genetic polymorphism, rs1345697, is associated with lower remission rates after antidepressant treatment: Findings from the METADAP cohort.
Poinsignon V; Colle R; Asmar KE; Mendez-David I; David DJ; Ait Tayeb AEK; Chappell K; Gressier F; Herrero H; Fève B; Becquemont L; Corruble E; Verstuyft C
J Affect Disord; 2022 Feb; 299():335-343. PubMed ID: 34906639
[TBL] [Abstract][Full Text] [Related]
4. Tobacco use is associated with low peripheral beta-arrestin 1 levels in major depression: A preliminary report.
Mesdom P; Colle R; Becquemont L; Chappell K; David DJ; Mendez-David I; Corruble E; Verstuyft C
Drug Alcohol Depend; 2022 Nov; 240():109653. PubMed ID: 36209675
[TBL] [Abstract][Full Text] [Related]
5. The ERICH3 rs11580409 polymorphism is associated with 6-month antidepressant response in depressed patients.
Chappell K; Colle R; Ait Tayeb AEK; Bouligand J; El-Asmar K; Deflesselle E; Fève B; Becquemont L; Corruble E; Verstuyft C
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Dec; 119():110608. PubMed ID: 35878676
[TBL] [Abstract][Full Text] [Related]
6. Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.
Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
J Psychopharmacol; 2015 May; 29(5):615-22. PubMed ID: 25294870
[TBL] [Abstract][Full Text] [Related]
7. SOD2 genetic polymorphism (rs4880) has no impact on 6-month response to antidepressant treatment and inflammatory biomarkers in depressed patients.
Ait Tayeb AEK; Becquemont L; El-Asmar K; Mahmoudi K; Colle R; Trabado S; Gressier F; Feve B; Corruble E; Verstuyft C
Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):289-295. PubMed ID: 31904901
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
9. The association of β-arrestin2 polymorphisms with response to antidepressant treatment in depressed patients.
Petit AC; El Asmar K; David DJ; Gardier AM; Becquemont L; Fève B; Verstuyft C; Corruble E
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():74-79. PubMed ID: 29031912
[TBL] [Abstract][Full Text] [Related]
10. Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients.
McCall WV; Lisanby SH; Rosenquist PB; Dooley M; Husain MM; Knapp RG; Petrides G; Rudorfer MV; Young RC; McClintock SM; Mueller M; Prudic J; Greenberg RM; Weiner RD; Bailine SH; Riley MA; McCloud L; Kellner CH;
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 28742292
[TBL] [Abstract][Full Text] [Related]
11. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3β genetic polymorphisms and insomnia in depressed patients: A prospective study.
Costemale-Lacoste JF; Colle R; Martin S; Asmar KE; Loeb E; Feve B; Verstuyft C; Trabado S; Ferreri F; Haffen E; Polosan M; Becquemont L; Corruble E
J Affect Disord; 2018 Nov; 240():230-236. PubMed ID: 30081294
[TBL] [Abstract][Full Text] [Related]
13. CLOCK gene variants associated with the discrepancy between subjective and objective severity in bipolar depression.
Suzuki M; Dallaspezia S; Locatelli C; Lorenzi C; Uchiyama M; Colombo C; Benedetti F
J Affect Disord; 2017 Mar; 210():14-18. PubMed ID: 27992853
[TBL] [Abstract][Full Text] [Related]
14. Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial.
Thase ME; Parikh SV; Rothschild AJ; Dunlop BW; DeBattista C; Conway CR; Forester BP; Mondimore FM; Shelton RC; Macaluso M; Li J; Brown K; Jablonski MR; Greden JF
J Clin Psychiatry; 2019 Oct; 80(6):. PubMed ID: 31721487
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder.
Henigsberg N; Mahableshwarkar AR; Jacobsen P; Chen Y; Thase ME
J Clin Psychiatry; 2012 Jul; 73(7):953-9. PubMed ID: 22901346
[TBL] [Abstract][Full Text] [Related]
16. Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales.
Luckenbaugh DA; Ameli R; Brutsche NE; Zarate CA
J Psychiatr Res; 2015 Feb; 61():40-5. PubMed ID: 25592045
[TBL] [Abstract][Full Text] [Related]
17. Rare Functional Variants Associated with Antidepressant Remission in Mexican-Americans: Short title: Antidepressant remission and pharmacogenetics in Mexican-Americans.
Wong ML; Arcos-Burgos M; Liu S; Licinio AW; Yu C; Chin EWM; Yao WD; Lu XY; Bornstein SR; Licinio J
J Affect Disord; 2021 Jan; 279():491-500. PubMed ID: 33128939
[TBL] [Abstract][Full Text] [Related]
18. A factor analytic study in bipolar depression, and response to lamotrigine.
Mitchell PB; Hadzi-Pavlovic D; Evoniuk G; Calabrese JR; Bowden CL
CNS Spectr; 2013 Aug; 18(4):214-24. PubMed ID: 23702258
[TBL] [Abstract][Full Text] [Related]
19. Depression Symptoms Predict Worse Clinical Response to Etanercept Treatment in Psoriasis Patients.
Jin W; Zhang S; Duan Y
Dermatology; 2019; 235(1):55-64. PubMed ID: 30408786
[TBL] [Abstract][Full Text] [Related]
20. ARRB1/β-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia.
Wang P; Xu TY; Wei K; Guan YF; Wang X; Xu H; Su DF; Pei G; Miao CY
Autophagy; 2014 Sep; 10(9):1535-48. PubMed ID: 24988431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
